Holen Sie sich die Stockscreener-App
48.41
0.95%
-0.46
Crispr Therapeutics Ag Aktie (CRSP) Neueste Nachrichten
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know - Yahoo Finance
Q2 EPS Estimate for CRISPR Therapeutics Lifted by Analyst - MarketBeat
Cathie Wood’s ARK Invest Buys $10M in CRISPR and PayPay on Thursday - CoinCentral
ARK Investment Acquires 113K Shares of Crispr Therapeutics (CRSP) - GuruFocus
Insider Selling: CRISPR Therapeutics (NASDAQ:CRSP) General Counsel Sells 2,800 Shares of Stock - MarketBeat
CRISPR Therapeutics (NASDAQ:CRSP) CEO Samarth Kulkarni Sells 9,798 Shares - MarketBeat
CRISPR Therapeutics (CRSP) CEO RSU vesting and 9,798-share tax sale - Stock Titan
Assessing CRISPR Therapeutics (CRSP) Valuation After Upsized US$550m Convertible Notes Offering - simplywall.st
CRISPR Therapeutics plans $350M convertible notes offering By Investing.com - Investing.com Nigeria
Research Analysts Set Expectations for CRSP FY2028 Earnings - MarketBeat
CRISPR Therapeutics prices $550M convertible notes offering By Investing.com - Investing.com Canada
CRISPR Therapeutics AG (CRSP) Falls Sharper Than Overall Market: Key Information to Note - Bitget
CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know - Yahoo Finance
CRISPR Therapeutics (CRSP) Reports $116M FY25 Revenue Driven by CASGEVY Growth - Insider Monkey
CRISPR Therapeutics Announces $350 Million Convertible Senior Notes Offering to Fund Gene-Editing Innovation - Minichart
CRISPR Therapeutics (CRSP) Sees Significant ARK Invest Purchase - GuruFocus
CRISPR Therapeutics (NASDAQ:CRSP) Sees Strong Trading VolumeHere's What Happened - MarketBeat
CRISPR Therapeutics prices $550 million convertible senior notes offering - The Pharma Letter
CRISPR Therapeutics (CRSP) Stock Plunges 10% as Cathie Wood’s ARK Invest Scoops Up Shares - MEXC
CRISPR Therapeutics (CRSP) Reports Wider Q4 Loss of $1.37/Share on Zero Revenue; Shares Plunge 10% - AlphaStreet
CRISPR Therapeutics (CRSP) Stock Drops 10% — Cathie Wood’s Ark Buys the Dip - MEXC
CRISPR Therapeutics (CRSP) Upsizes Convertible Note Offering to $550M - GuruFocus
CRISPR Therapeutics (CRSP) Announces $550M Convertible Notes Offering - GuruFocus
Crispr Therapeutics Upsizes Convertible Notes Offering to $550 Million - TipRanks
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering - The Manila Times
CRISPR Therapeutics prices $550M upsized convertible notes due 2031 - TradingView
CRISPR Therapeutics AG Prices $550 Million Convertible Senior Notes Offering Due 2031 - Quiver Quantitative
CRISPR Therapeutics prices $550M convertible notes offering - Investing.com
Investors back CRISPR $550M notes, 45% premium conversion price - Stock Titan
CRISPR Therapeutics (CRSP) Stock Plunges 10% as Cathie Wood's ARK Invest Scoops Up Shares - Blockonomi
Cathie Wood buys the dip in gene-editing firm CRISPR Therapeutics (CRSP:NASDAQ) - Seeking Alpha
Capital International Investors Acquires 55,511 Shares of CRISPR Therapeutics AG $CRSP - MarketBeat
CRISPR Therapeutics (CRSP) Announces $350M Convertible Notes Off - GuruFocus
This Is Why CRISPR Therapeutics Stock Is Tumbling on Tuesday - The Motley Fool
This Is Why CRISPR Therapeutics Stock Is Tumbling on Tuesday - The Motley Fool
Why is CRSP stock falling pre-market today? - MSN
CRSP Stock Declines Over 9% as Market Faces Downturn - GuruFocus
What's Going On With CRISPR Therapeutics Stock Today? - Benzinga
CRISPR Therapeutics (NASDAQ:CRSP) Shares Gap DownWhat's Next? - MarketBeat
Crispr Therapeutics Falls on $350 Million Senior Note Private Placement - marketscreener.com
Here is Why CRISPR Therapeutics (CRSP) Appears so Good - Bitget
CRISPR Therapeutics plans $350M convertible notes offering - Investing.com India
CRISPR Therapeutics stock dips on $350M convertible debt offering - MSN
Crispr Therapeutics Plans $350 Million Convertible Senior Notes Offering - marketscreener.com
Crispr Therapeutics announces proposed convertible senior notes offering - TipRanks
CRISPR Therapeutics stock falls on convertible notes offering - Investing.com India
Why Crispr Therapeutics Stock Is Sliding Today - TipRanks
CRISPR Therapeutics stock falls on convertible notes offering By Investing.com - Investing.com UK
CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering - The Manila Times
CRISPR Therapeutics seeks $350M in 2031 convertible debt - Stock Titan
Why Is CRSP (CRISPR Therapeutics) Stock Falling Pre-Market Today? - Stocktwits
Is A Vertex Buyout Of Crispr Therapeutics Inevitable? Here's My Take (NASDAQ:CRSP) - Seeking Alpha
CRISPR Therapeutics Pivots Beyond Casgevy, Highlights CTX310 Data and New Cardiovascular Push - MarketBeat
Is CRISPR Therapeutics AG stock attractive for income investorsJuly 2025 EndofMonth & Capital Efficient Trade Techniques - Naître et grandir
CRISPR Therapeutics AG (CRSP) a Moderate Buy, Per Wall Street - Finviz
CRISPR Therapeutics (CRSP) Is Down 6.1% After Highlighting Casgevy Rollout And 2025 Net LossWhat's Changed - Sahm
Wall Street Analysts See CRISPR Therapeutics (CRSP) as a Buy: Should You Invest? - MSN
SR One Capital Management LP Has $132.13 Million Stock Position in CRISPR Therapeutics AG $CRSP - MarketBeat
Assessing CRISPR Therapeutics (CRSP) Valuation As Casgevy Expectations and Forecast Revisions Draw Investor Focus - Sahm
Casgevy Uptake Grows As CRISPR Therapeutics Shares Trade Below Estimates - Sahm
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):